Endo Ventures Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ENDO VENTURES, and what generic alternatives to ENDO VENTURES drugs are available?
ENDO VENTURES has one approved drug.
There are three US patents protecting ENDO VENTURES drugs.
There are fourteen patent family members on ENDO VENTURES drugs in eight countries.
Drugs and US Patents for Endo Ventures
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Endo Ventures Ltd | SUMAVEL DOSEPRO | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 022239-001 | Jul 15, 2009 | DISCN | Yes | No | 7,776,007 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Endo Ventures Ltd | SUMAVEL DOSEPRO | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 022239-001 | Jul 15, 2009 | DISCN | Yes | No | 7,901,385 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Endo Ventures Ltd | SUMAVEL DOSEPRO | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 022239-001 | Jul 15, 2009 | DISCN | Yes | No | 8,287,489 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Endo Ventures Ltd | SUMAVEL DOSEPRO | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 022239-002 | Nov 26, 2013 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Endo Ventures
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Endo Ventures Ltd | SUMAVEL DOSEPRO | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 022239-001 | Jul 15, 2009 | 8,343,130 | ⤷ Sign Up |
Endo Ventures Ltd | SUMAVEL DOSEPRO | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 022239-001 | Jul 15, 2009 | 6,251,091 | ⤷ Sign Up |
Endo Ventures Ltd | SUMAVEL DOSEPRO | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 022239-001 | Jul 15, 2009 | 6,280,410 | ⤷ Sign Up |
Endo Ventures Ltd | SUMAVEL DOSEPRO | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 022239-001 | Jul 15, 2009 | 5,891,086 | ⤷ Sign Up |
Endo Ventures Ltd | SUMAVEL DOSEPRO | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 022239-001 | Jul 15, 2009 | 6,681,810 | ⤷ Sign Up |
Endo Ventures Ltd | SUMAVEL DOSEPRO | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 022239-001 | Jul 15, 2009 | 8,267,903 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Endo Ventures Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Canada | 2479316 | ⤷ Sign Up |
European Patent Office | 1689465 | ⤷ Sign Up |
European Patent Office | 1487517 | ⤷ Sign Up |
Japan | 4504688 | ⤷ Sign Up |
United Kingdom | 0206560 | ⤷ Sign Up |
Spain | 2290443 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.